- Home
- BBIO vs BIDU Comparison
BBIO vs BIDU Comparison
Compare BBIO & BIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BIDU
- Stock Information
- Founded
- BBIO 2015
- BIDU 2000
- Country
- BBIO United States
- BIDU China
- Employees
- BBIO N/A
- BIDU N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BIDU Computer Software: Programming Data Processing
- Sector
- BBIO Health Care
- BIDU Technology
- Exchange
- BBIO Nasdaq
- BIDU Nasdaq
- Market Cap
- BBIO 9.4B
- BIDU 30.9B
- IPO Year
- BBIO 2019
- BIDU 2005
- Fundamental
- Price
- BBIO $51.18
- BIDU $137.83
- Analyst Decision
- BBIO Strong Buy
- BIDU Strong Buy
- Analyst Count
- BBIO 16
- BIDU 9
- Target Price
- BBIO $64.44
- BIDU $115.11
- AVG Volume (30 Days)
- BBIO 2.1M
- BIDU 7.2M
- Earning Date
- BBIO 11-11-2025
- BIDU 08-20-2025
- Dividend Yield
- BBIO N/A
- BIDU N/A
- EPS Growth
- BBIO N/A
- BIDU 41.81
- EPS
- BBIO N/A
- BIDU 10.88
- Revenue
- BBIO $235,812,000.00
- BIDU $18,544,068,789.00
- Revenue This Year
- BBIO $115.97
- BIDU N/A
- Revenue Next Year
- BBIO $65.50
- BIDU $5.07
- P/E Ratio
- BBIO N/A
- BIDU $12.67
- Revenue Growth
- BBIO 7.62
- BIDU N/A
- 52 Week Low
- BBIO $21.72
- BIDU $74.71
- 52 Week High
- BBIO $54.60
- BIDU $137.94
- Technical
- Relative Strength Index (RSI)
- BBIO 52.52
- BIDU 90.32
- Support Level
- BBIO $49.94
- BIDU $106.81
- Resistance Level
- BBIO $54.29
- BIDU $116.91
- Average True Range (ATR)
- BBIO 2.14
- BIDU 3.65
- MACD
- BBIO -0.28
- BIDU 3.37
- Stochastic Oscillator
- BBIO 35.71
- BIDU 99.66
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.